Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)

J. Donald Easton(University of California, San Francisco), David Paulon, Robin Lemmens(VIB-KU Leuven Center for Microbiology), Pierre Amarenco(Assistance Publique – Hôpitaux de Paris), Gregory W. Albers(Stanford University), Kazuo Minematsu(Kishokai Medical Corporation), Sandra Lepera, Pablo Lavados, Hans Denison(Université Sorbonne Paris Nord), Anna Członkowska(Institute of Psychiatry and Neurology), Marina Romano(Heidelberg University), Geoffrey Donnan, Nils Wahlgren(Karolinska Institutet), Maria Aunes(Stanford University), Kürşad Kutluk(Dokuz Eylül University), Sara Bokelund-Singh(Stanford University), K.S. Lawrence Wong(Stanford University), Michael D. Hill(University of Calgary), S. Claiborne Johnston(Stanford University), Jong-Sung Kim, Yongjun Wang(Stanford University), Sebastiá Ameriso(The University of Melbourne), Daniel Laskowitz, Angel Arauz Góngora, Ayrton Massaro, Ekaterina Titianova, Carlos Molina(Beijing Tian Tan Hospital), Nijasri Charnnarong Suwanwela, Maria Jahreskog(Stanford University), Scott R. Evans(Stanford University), Sebastian Ameriso, Norio Tanahashi(UMass Memorial Health Care), Peter Held(AstraZeneca (Sweden)), Wayne Clark, Huy Thang Nguyen, Ovidiu Bajenaru, Miroslav Brozman, Patrik Michel(University Hospital of Lausanne), Ludmila Stakhovskaya, Giancarlo Agnelli, Edwin Pretell, Tsong Hai Lee, Jenny Jonasson(AstraZeneca (Sweden)), Scott Kasner, Szegedi Norbert
Circulation
June 27, 2017
Cited by 33


Related Papers